Description
Milucant (montelukast sodium) Chewing Tablets 4 mg.
Milucant is a medication that contains montelukast sodium as its active ingredient. It is available in the form of chewable tablets with a strength of 4 mg. These tablets are commonly prescribed to treat various respiratory conditions, particularly asthma and allergic rhinitis.
What is Montelukast Sodium?
Montelukast sodium is a leukotriene receptor antagonist that works by blocking the action of certain chemicals in the body that cause inflammation, bronchoconstriction, and other symptoms associated with asthma and allergies. By inhibiting these chemicals, montelukast helps to reduce inflammation in the airways and improve breathing in patients with respiratory conditions.
Indications
Milucant chewing tablets are indicated for the following conditions:
- Asthma: Milucant is used for the prophylaxis and chronic treatment of asthma in adults and children aged 2 years and older.
- Allergic Rhinitis: Milucant is also indicated for the relief of symptoms of allergic rhinitis in adults and children aged 2 years and older.
Dosage and Administration
The recommended dosage of Milucant chewable tablets is determined by the patient’s age and the condition being treated. It is important to follow the dosage instructions provided by your healthcare provider or as indicated on the packaging. The tablets should be chewed thoroughly before swallowing, and can be taken with or without food.
For Asthma:
For adults and adolescents aged 15 years and older, the usual dose is one 4 mg. chewable tablet daily. For children aged 6 to 14 years, the recommended dose is one 4 mg. chewable tablet daily. For children aged 2 to 5 years, the dose should be determined by a healthcare provider based on the child’s weight.
For Allergic Rhinitis:
The recommended dose for adults and adolescents aged 15 years and older is one 4 mg. chewable tablet daily. For children aged 6 to 14 years, the usual dose is one 4 mg. chewable tablet daily. The dose for children aged 2 to 5 years should be determined by a healthcare provider based on the child’s weight.
Contraindications
Milucant chewable tablets are contraindicated in patients with a known hypersensitivity to montelukast or any of the tablet’s excipients. It should not be used in patients with severe hepatic impairment or phenylketonuria due to the presence of aspartame in the tablets.
Adverse Reactions
As with any medication, Milucant may cause side effects in some patients. Common adverse reactions associated with montelukast sodium include:
- Headache
- Abdominal pain
- Diarrhea
- Thirst
- Nausea
- Vomiting
If any of these side effects persist or worsen, it is important to consult a healthcare provider for further guidance.
Precautions
Before taking Milucant chewable tablets, inform your healthcare provider if you have any of the following conditions:
- History of liver disease
- Phenylketonuria
- Pregnancy or breastfeeding
- Use of other medications, including herbal supplements
It is important to disclose this information to your healthcare provider to ensure the safe and effective use of this medication.
Storage
Milucant chewable tablets should be stored at room temperature (20-25°C or 68-77°F) in a dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children.
Conclusion
Milucant (montelukast sodium) chewing tablets 4 mg. are a commonly prescribed medication for the treatment of asthma and allergic rhinitis in adults and children. By blocking the action of certain chemicals in the body, montelukast sodium helps to reduce inflammation in the airways and improve breathing in patients with respiratory conditions. It is important to follow the dosage instructions provided by your healthcare provider and to be aware of any potential side effects or contraindications associated with this medication. If you have any questions or concerns about taking Milucant, consult your healthcare provider for further guidance.
